Variant report
Variant | esv3324088 |
---|---|
Chromosome Location | chr17:46729378-46731926 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:3)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:3 , 50 per page) page:
1
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000272763 | TF binding region |
ENSG00000170689 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs144444408 | chr17:46729501-46729502 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs368375505 | chr17:46729513-46729514 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs150666529 | chr17:46729518-46729519 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs182374656 | chr17:46729548-46729549 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs28870735 | chr17:46729629-46729630 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs139806688 | chr17:46729676-46729677 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs561573370 | chr17:46729685-46729686 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs530406041 | chr17:46729690-46729691 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs149794960 | chr17:46729696-46729697 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs560096411 | chr17:46729705-46729706 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs35511991 | chr17:46729821-46729822 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs372420923 | chr17:46729866-46729867 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs57993225 | chr17:46729867-46729868 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs35944007 | chr17:46729879-46729880 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs532504457 | chr17:46729887-46729888 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs552414455 | chr17:46729930-46729931 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs566121395 | chr17:46729945-46729946 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs60118017 | chr17:46729952-46729953 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs547179907 | chr17:46729965-46729966 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs4793597 | chr17:46729996-46729997 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs186873592 | chr17:46730052-46730053 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs191768776 | chr17:46730069-46730070 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs181254524 | chr17:46730076-46730077 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs34255291 | chr17:46730099-46730100 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs534303287 | chr17:46730148-46730149 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs575962405 | chr17:46730159-46730160 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs185364311 | chr17:46730166-46730167 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs558371771 | chr17:46730181-46730182 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs189735602 | chr17:46730313-46730314 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs182081484 | chr17:46730329-46730330 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs572130815 | chr17:46730401-46730402 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs554144643 | chr17:46730417-46730418 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs139865227 | chr17:46730465-46730466 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs200874650 | chr17:46730467-46730468 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs201685604 | chr17:46730471-46730472 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs200304588 | chr17:46730473-46730474 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs375976220 | chr17:46730475-46730476 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs201458214 | chr17:46730485-46730486 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs58028542 | chr17:46730486-46730487 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs8071227 | chr17:46730494-46730495 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs541682680 | chr17:46730506-46730507 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs8067301 | chr17:46730562-46730563 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs187831436 | chr17:46730578-46730579 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs71144510 | chr17:46730582-46730583 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs12953273 | chr17:46730590-46730591 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs200143026 | chr17:46730591-46730592 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs12953277 | chr17:46730592-46730593 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs66843967 | chr17:46730593-46730594 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs61394116 | chr17:46730594-46730595 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs34758496 | chr17:46730595-46730596 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Melanoma | 18172304 | CNVD |
Moyamoya disease | 22323933 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Cancer | 16751803 | CNVD |
Chordoma | 21602918 | CNVD |
Neurofibromatosis | 20686819 | CNVD |
Peripheral nerve sheath tumors | 20686819 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Breast cancer | 21264507 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Gastric cancer | 17167181 | CNVD |
Breast cancer | 19287154 | CNVD |
Leukemia | 20874852 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Breast cancer | 17457667 | CNVD |
Breast cancer | 16951389 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 22048815 | CNVD |
Breast cancer | 17603634 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 20953835 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
TAR Syndrome | 17847015 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 19261255 | CNVD |
Lung cancer | 16773561 | CNVD |
Neurocytoma | 17123091 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Basal-like breast cancer | 18066063 | CNVD |
Breast cancer | 20031965 | CNVD |
Colorectal cancer | 19287155 | CNVD |
Hereditary breast | 19566914 | CNVD |
Ovarian cancer | 19047089 | CNVD |
Ovarian cancer | 19566914 | CNVD |
Triple-negative breast cancer | 18950515 | CNVD |
Breast cancer | 16846527 | CNVD |
Bladder cancer | 21909424 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ewing''s sarcoma | 18628472 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 16397240 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Prostate cancer | 17217626 | CNVD |
Non-syndromic sensorineural hearing loss | 21084979 | CNVD |
Autism | 22817714 | CNVD |
Breast cancer | 20409316 | CNVD |
Cancer | 17160897 | CNVD |
Frontotemporal lobar degeneration | 19640594 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Breast cancer | 21509527 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:46725400-46739000 | Weak transcription | Sigmoid Colon | Sigmoid Colon |
2 | chr17:46725600-46732000 | Weak transcription | Rectal Mucosa Donor 31 | rectum |
3 | chr17:46725600-46749000 | Weak transcription | A549 | lung |
4 | chr17:46726000-46729400 | Weak transcription | GM12878-XiMat | blood |
5 | chr17:46729400-46730200 | Enhancers | GM12878-XiMat | blood |
6 | chr17:46730000-46733200 | Weak transcription | Rectal Mucosa Donor 29 | rectum |